ENHYPEN has achieved a high position on the U.S. Billboard Main Album Chart with their new album.

On the 29th, Billboard announced the latest chart (as of December 2). ENHYPEN's 5th mini-album 'ORANGE BLOOD' entered the 'Billboard 200' at 4th place.

This marks their sixth consecutive entry into the chart, starting with their 2nd mini-album 'BORDER: CARNIVAL.' Their previous album, 'DARK BLOOD,' also secured a position within the 'Top 5.'

They secured top spots on a total of five album charts, including 1st place on the 'World Albums,' and 2nd places on both 'Top Album Sales' and 'Top Current Album Sales.' Additionally, they ranked 6th on the 'Tastemaker Albums' chart, demonstrating their global influence.

ENHYPEN's title track from the new album, 'Sweet Venom,' also made impressive strides, securing the 5th position on both the 'Artist 100' and 'World Digital Song Sales' charts. This achievement represents the highest ranking among K-pop artists on these charts for the week.

'Sweet Venom' also reached 61st place on the 'Billboard Global' chart (excluding the U.S.) and 104th place on the 'Global 200.' This is an improvement of 29 and 36 spots, respectively, compared to the entry ranking of their previous title track, 'BITE ME.'

ENHYPEN released 'ORANGE BLOOD' on the 17th, surpassing 1,871,269 copies in first-week sales (according to Hanteo Chart), setting a new record for their own first-week sales.

<Photo=Belift Lab>

<Translated by=Gawon Park(Dispatch)>